Pembrolizumab in Triple-Negative Breast Cancer. Altundag K. N Engl J Med 2022;387:1435-1436.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Altundag K. Pembrolizumab in Triple-Negative Breast Cancer. N Engl J Med 2022;387:1435-1436.
PMID: 36239657